NEW YORK and BERLIN, Sept. 07, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following investor conferences in September: Citi’s 17th Annual BioPharma Conference in Boston Format: Industry Panel Date and Time: Wednesday, September 7th, 10:30 a.


Previous articleMindset Pharma Files National Patents Protecting Family 1 Application in 16 Different Countries
Next articlePsyence Group Announces Amendment and Closing of Previously Announced Private Placement